Lupin Limited (LUPIN) secures U.S. FDA approval for Modafinil Tablets, expanding its generics portfolio with a bioequivalent to Provigil®.
Natco Pharma Limited (NSE: NATCO PHARM) receives tentative approval from U.S. FDA for Olaparib tablets, bioequivalent to Lynparza.
Sun Pharmaceutical Industries Limited (SUNPHARMA) announced approval to manufacture and market generic semaglutide in South Africa.
Alembic Pharmaceuticals Limited (APLLTD) announced USFDA final approval for Oseltamivir Phosphate Oral Suspension, 6 mg/mL, expanding its generic drug portfo.
Lupin Limited (LUPIN) secures tentative approval from U.S. FDA for Enzalutamide Tablets, expanding dosage options.
Aurobindo Pharma Limited (AUROPHARMA) secures final approval from US FDA for Tofacitinib Tablets, targeting a US$494 million market.
Lupin Limited (NSE: LUPIN) secures U.S. FDA approval for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, marking a significant milestone.
Alembic Pharmaceuticals Limited (APLLTD) announced USFDA tentative approval for Darolutamide Tablets, 300 mg, with an estimated market size of US$ 3,155 million.